Alembic Pharmaceuticals gains as its arm set to acquire Utility Therapeutics

Alembic Pharmaceuticals jumps on getting USFDA’s tentative nod for Darolutamide Tablets

Alembic Pharmaceuticals is currently trading at Rs 1000.60, up by 10.95 points or 1.11% from its previous closing of Rs 989.65 on the BSE. The scrip opened at Rs 999.05 and has touched a high and low of Rs 1010.00 and Rs 980.00 respectively. So far 20842 shares were traded on the counter. The BSE … Read more

Alembic Pharmaceuticals zooms on getting final nod for Doxorubicin Hydrochloride Liposome Injection

Alembic Pharmaceuticals

Alembic Pharmaceuticals is currently trading at Rs. 1078.25, up by 106.40 points or 10.95% from its previous closing of Rs. 971.85 on the BSE. The scrip opened at Rs. 1029.75 and has touched a high and low of Rs. 1089.80 and Rs. 990.20 respectively. So far 97681 shares were traded on the counter. The BSE … Read more

Alembic Pharmaceuticals moves up on getting USFDA’s nod for Dabigatran Etexilate Capsules

alembic pharmaceuticals gets usfda approval for solifenacin succinate tablets

Alembic Pharmaceuticals is currently trading at Rs. 873.20, up by 5.75 points or 0.66% from its previous closing of Rs. 867.45 on the BSE. The scrip opened at Rs. 883.25 and has touched a high and low of Rs. 894.00 and Rs. 871.00 respectively. So far 3239 shares were traded on the counter. The BSE … Read more

Alembic Pharma rises on getting tentative USFDA’s nod for breast cancer drug

alembic pharmaceuticals gets usfda approval for solifenacin succinate tablets

Alembic Pharmaceuticals is currently trading at Rs. 1013.55, up by 8.70 points or 0.87% from its previous closing of Rs. 1004.85 on the BSE. The scrip opened at Rs. 1008.95 and has touched a high and low of Rs. 1035.00 and Rs. 1003.80 respectively. So far 3128 shares were traded on the counter. The BSE … Read more

Alembic Pharmaceuticals gets USFDA’s final approval for Cyclophosphamide Capsules

alembic pharmaceuticals gets usfda approval for solifenacin succinate tablets

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Cyclophosphamide Capsules, 25 mg and 50 mg. he approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Cyclophosphamide Capsules, 25 mg and 50 mg, of Hikma Pharmaceuticals USA Inc. Cyclophosphamide … Read more

Alembic Pharmaceuticals zooms on getting final nod for Ketorolac Tromethamine Injection

alembic pharmaceuticals gets usfda approval for solifenacin succinate tablets

Alembic Pharmaceuticals is currently trading at Rs. 661.55, up by 49.35 points or 8.06% from its previous closing of Rs. 612.20 on the BSE. The scrip opened at Rs. 608.70 and has touched a high and low of Rs. 675.00 and Rs. 603.55 respectively. So far 143890 shares were traded on the counter. The BSE … Read more

Alembic Pharmaceuticals rises on getting USFDA tentative nod for Dasatinib tablets

alembic pharmaceuticals gets usfda approval for solifenacin succinate tablets

Alembic Pharmaceuticals is currently trading at Rs. 735.70, up by 3.60 points or 0.49% from its previous closing of Rs. 732.10 on the BSE. The scrip opened at Rs. 730.00 and has touched a high and low of Rs. 740.90 and Rs. 728.90 respectively. So far 1704 shares were traded on the counter. The BSE … Read more

BREAKING NEWS:
“Prateek Yadav dreams of owning a ₹5 crore ‘Blue Bolt'” Kia Sonet’s Second Generation: Enhanced Safety and Features! Will WhatsApp require a subscription? Discover the truth!